Top Covid Vaccine Maker Goes From Financial Loss To $4 Billion Profit
From losing hundreds of millions to “turning their profits around on a dime,” the finances of BioNTech tell the story of the great Covid revolution.
Global Elite
From losing hundreds of millions to “turning their profits around on a dime,” the finances of BioNTech tell the story of the great Covid revolution.